SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos.
Title in Spanish as published on TED.
Contract award notice published on TED on 7 Oct 2026 by Servicio Murciano de Salud - Junta de Compras (Spain), CPV 33652000 Antineoplastic and immunomodulating agents. Awarded to JANSSEN CILAG, S.A., ABBVIE SPAIN, S.L.U., PFIZER, S.L.U. and 1 more for EUR 27,609,248.
| Notice | 690933-2026 (can-standard) |
|---|---|
| Status | Contract award |
| Published | 7 Oct 2026 |
| Buyer | Servicio Murciano de Salud - Junta de Compras, Espinardo |
| Country | Spain |
| Main CPV | 33652000-5 Antineoplastic and immunomodulating agents |
| Contract type | supplies |
| Procedure | neg wo call |
| Estimated value | EUR 74,544,970 excl. VAT |
| Awarded value | EUR 27,609,248 |
| Tenders received | 1 |
| Award decision | 8 Sep 2026 |
Join the Pro waitlist
Pro adds monitoring, alerts and bulk exports across Initask sites. Leave your email and we will write when it opens.
Description
Suministro de medicamentos exclusivos con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos.
Lots (10)
| Lot | Title | Estimated value | Deadline |
|---|---|---|---|
| LOT-0001 | Daratumumab 1.800 mg /15 ml solucion inyectable 1 vial | EUR 57,848,918 | |
| LOT-0002 | Cemiplimab 350 mg vial concentrado para solucion perfusion | EUR 5,026,374 | |
| LOT-0003 | Talquetamab 2 mg/ml solucion inyectable 1 vial 1,5 ml | EUR 118,508 | |
| LOT-0004 | Talquetamab 40 mg/ml solucion inyectable 1 vial 1 ml | EUR 4,740,250 | |
| LOT-0005 | Glecaprevir/pibrentasvir 100/40 mg 84 comprimidos recubiertos | EUR 2,185,313 | |
| LOT-0006 | Epcoritamab 4 mg/0,8 ml concentrado sol perf vial 0,8 ml | EUR 95,326 | |
| LOT-0007 | Epcoritamab 48 mg solucion inyectable vial 0,8 ml | EUR 2,859,759 | |
| LOT-0008 | Atogepant 60 mg 28 comprimidos | EUR 603,364 | |
| LOT-0009 | Rimegepant 75 mg liofilizado oral 16 comprimidos | EUR 395,604 | |
| LOT-0010 | Ritlecitinib 50 mg capsulas duras | EUR 671,555 |
Winners
Other CPV codes
More Antineoplastic and immunomodulating agents in Spain
Suministro sucesivo de los medicamentos de inmunoterapia oncológica para el Área de Santiago de Compostela y Barbanza
Award · Antineoplastic agents · 7 Oct 2026 · Spain · Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza · value EUR 9,228,285 · won by ROCHE FARMA, S.A., MERCK, S.L.U.
LOT-0001
Award · Immunosuppressive agents · 6 Oct 2026 · Spain · HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS · value EUR 720,486 · won by ALEXION PHARMA SPAIN, SLU
Suministro sucesivo del medicamento "Axicabtagen Ciloleucel"
Award · Antineoplastic agents · 29 Sep 2026 · Spain · Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud · won by GILEAD SCIENCES, S.L.
Suministro sucesivo de diversos medicamentos para el tratamiento del Mieloma Múltiple (MM) para los centros hospitalarios del Área Sanitaria de Lugo, A Mariña y Monforte de Lemos
Award · Antineoplastic agents · 29 Sep 2026 · Spain · Servicio Gallego de Salud - Área Sanitaria de Lugo, A Mariña y Monforte de Lemos · value EUR 6,475,019 · won by AMGEN S.A., JANSSEN-CILAG S.A.
Adquisición del medicamento Infliximab
Tender · Antineoplastic and immunomodulating agents · 23 Sep 2026 · Spain · Hospital Universitario Infanta Leonor · value EUR 676,396 · deadline 23 Oct 2026
Suministro de adquisición del Scemblix para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.
Award · Antineoplastic agents · 21 Sep 2026 · Spain · HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL · value EUR 769,615 · won by NOVARTIS Farmacéutica S.A.,
Get new antineoplastic and immunomodulating agents tenders by email
A free weekly digest of new competition notices for this CPV code and country, straight from TED.
Set up a free alert